Sage Tea Drinking Improves Lipid Profile and Antioxidant Defences in Humans by Sá, Carla M. et al.
Int. J. Mol. Sci. 2009, 10, 3937-3950; doi:10.3390/ijms10093937 
 
International Journal of 
Molecular Sciences 
ISSN 1422-0067 
www.mdpi.com/journal/ijms 
Article 
Sage Tea Drinking Improves Lipid Profile and Antioxidant 
Defences in Humans  
Carla M. Sá 
1, Alice A. Ramos 
1, Marisa F. Azevedo 
1, Cristovao F. Lima 
2, Manuel  
Fernandes-Ferreira 
2 and Cristina Pereira-Wilson 
1,*
 
1  CBMA–Centre of Molecular and Environmental Biology/Department of Biology, School of 
Sciences, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal;  
E-Mails: carlasa@bio.uminho.pt (C.M.S.); aliceramos@bio.uminho.pt (A.A.R.); 
marisazevedo@gmail.com (M.F.A.) 
2  CITAB–Centre for the Research and Technology of Agro-Environment and Biological 
Sciences/Department of Biology, School of Sciences, University of Minho, 4710-057 Braga, 
Portugal; E-Mails: lima@bio.uminho.pt (C.F.L.); mfferreira@bio.uminho.pt (M.F.F.) 
*  Author to whom correspondence should be addressed; E-Mail: cpereira@bio.uminho.pt;  
Tel. +351-253604318; Fax: +351-253678980. 
Received: 1 July 2009; in revised form: 25 August 2009 / Accepted: 8 September 2009 /  
Published: 9 September 2009 
 
Abstract: Salvia officinalis (common sage) is a plant with antidiabetic properties. A pilot 
trial (non-randomized crossover trial) with six healthy female volunteers (aged 40-50) was 
designed to evaluate the beneficial properties of sage tea consumption on blood glucose 
regulation, lipid profile and transaminase activity in humans. Effects of sage consumption 
on erythrocytes’ SOD and CAT activities and on Hsp70 expression in lymphocytes were 
also evaluated.  Four weeks sage tea treatment had no effects on plasma glucose. An 
improvement in lipid profile was observed with lower plasma LDL cholesterol and total 
cholesterol levels as well as higher plasma HDL cholesterol levels during and two weeks 
after treatment. Sage tea also increased lymphocyte Hsp70 expression and erythrocyte 
SOD and CAT activities. No hepatotoxic effects or other adverse effects were observed.  
Keywords:  Salvia officinalis L.; type 2 diabetes mellitus; lipid profile; human trial; 
antioxidant defences 
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1. Introduction  
 
Diabetes mellitus is a serious public health problem characterized by deficient plasma glucose 
regulation due to tissue insulin resistance and/or β-cell failure which causes high morbidity and 
mortality rates. Type 2 diabetes (T2DM) accounts for the majority cases of diabetes (about 90%) and 
is becoming more prevalent due to the increasing rates of obesity in youth and adulthood and 
sedentary lifestyles [1].  
Dyslipidaemia is also common among diabetic patients and plays a critical role in the development 
of cardiovascular complications.  Metabolic dyslipidaemia is characterised by high levels of 
triglycerides, associated with low levels of high-density lipoprotein cholesterol–HDL-C with or 
without a raise in low-density lipoprotein cholesterol–LDL-C [2-5]. These imbalances in the internal 
metabolic environment, combined with the characteristic low antioxidant defences of diabetics can 
lead to oxidative stress and cellular damage. Oxidative stress has been demonstrated to be a 
contributor to the progression of the disease, accelerating both β-cell failure and cardiovascular 
complications. Antioxidant enzymes, such as superoxide dismutase (SOD) and catalase (CAT) play 
crucial roles in the cellular protection against oxidative damage eliminating reactive oxygen species 
(ROS) [6,7].  
The increased expression of heat shock proteins (Hsp) is regarded as one of the most powerful 
means of cytoprotection against loss of cellular homeostasis and Hsp levels have been shown to be 
involved in tissue insulin responsiveness [8]. The study of levels of cell protection in the most relevant 
insulin sensitive tissues is highly invasive and the easily accessible lymphocyte may provide valuable 
biomarkers of health status [9,10]. The Hsp70 levels of lymphocytes may therefore provide 
information on effects on insulin response. 
T2DM is preventable through lifestyles changes (including diet changes, physical exercise and 
weight loss) and pharmacological interventions with drugs such as metformin and acarbose [11-13]. 
Herbal teas with glucose-lowering properties may offer low-cost alternatives to pharmacological 
interventions to limit the progression of the disease while having good acceptance. In particular 
Momordica charantia has been shown to improve insulin secretion in β-cells, increase peripheral 
glucose uptake, significantly reduce serum cholesterol and triglycerides levels at the same time as 
increasing HDL-C levels [14]; Coccinia indica improves antioxidant status by increasing antioxidant 
defences such as SOD, CAT and reduced glutathione levels and shows a significant hypoglycaemic 
action by decreasing blood glucose levels and increasing hepatic glycogen synthesis in animal models 
[15,16] and Camellia sinensis, has been associated with weight reduction, decrease in blood pressure 
and blood glucose levels, protection against lipid peroxidation and improvement of blood lipid profile 
which suggest beneficial effects against obesity, cardiovascular diseases (CVD) and T2DM [17-19]. 
Common sage (Salvia officinalis) is among the plants to which antidiabetic properties have been 
attributed by popular medicine and its extracts showed to possess hypoglycaemic effects in normal and 
diabetic animals [20,21]. In a previous study we have shown that treatment with sage tea for 14 days 
lowered fasting plasma glucose levels but had no effects on glucose clearance in response to an 
intraperitoneal glucose tolerance test (ipGTT) in rats [22]. Using hepatocyte primary cultures a 
decreased gluconeogenesic response to glucagon and a higher responsiveness to insulin were found Int. J. Mol. Sci. 2009, 10                 
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after in vivo treatment with sage tea [22]. In vivo treatments with Salvia fruticosa tea also reduced 
plasma glucose in STZ rats (unpublished observations). 
With the purpose of studying the effects of sage tea consumption on glucose regulation in humans, 
a pilot trial with human volunteers was carried out where a number of parameters relevant to diabetes 
were analysed such as fasting and postprandial blood glucose, response to an oral glucose tolerance 
test–OGTT, lipid profile, liver toxicity and antioxidant defences. Demonstration that there is no 
toxicity or adverse effects associated with sage consumption paves the way for future studies involving 
diabetic patients where the true antidiabetic potential of sage will have to be tested. 
 
2. Results and Discussion  
 
2.1. Effects of Salvia officinalis on Blood Glucose Regulation, Plasma Aminotransferase Activity, 
Blood Pressure, Heart Rate at Rest and Body Weight  
 
In this study we evaluated in healthy women volunteers the effects of Salvia officinalis (sage) tea 
drinking (300 mL, twice a day) on parameters relevant to diabetes and its associated cardiovascular 
complications. In spite of its claimed antidiabetic potential and traditional use, no effects on blood 
glucose were observed in healthy humans (Table 1). In our previous work, sage tea drinking decreased 
fasting blood glucose in normoglycemic mice [22]. Since no such effects on fasting blood glucose 
were found in the present study (Table 1), the risk of hypoglycaemia is excluded. Sage tea drinking 
improved lipid profile and increased antioxidant defences (see below) which may indirectly improve 
the diabetic condition. 
Table 1. Physiological and biochemical parameters during the different phases of the trial: 
baseline (B), second (T2) and fourth (T4) week of sage tea treatment and wash-out (W). 
Parameters  
Phases of the trial 
B T2  T4  W 
Weight (kg)  56.2 ± 7.1  56.2 ± 6.1  55.6 ± 6.1  55.9 ± 5.9 
Systolic blood pressure (mmHg)   116.1 ± 10.3  110.3 ± 14.5  110.7 ± 15.5  107.7 ± 13.2 
Diastolic blood pressure 
(mmHg) 
68.2 ± 9.4  64.5 ± 14.0  63.6 ± 11.7  59.5 ± 9.1 
Heart rate at rest (beats/min)  65.9 ± 10.7  67.2 ± 10.9  66.6 ± 8.2  68.7 ± 9.9 
ALT (IU/L)  7.3 ± 1.0  6.8 ± 1.4  8.4 ± 1.6  7.6 ± 1.5 
AST (IU/L)  8.1 ± 1.1  10.0 ± 2.0  10.6 ± 1.8 *  9.8 ± 1.2 
Fasting glucose levels 
a (mM)  4.31 ± 1.18  4.60 ± 0.92  4.21 ± 1.54  --- 
Postprandial glucose levels 
a 
(mM) 
5.33 ± 1.64  4.35 ± 0.53  4.88 ± 0.94  4.58 ± 0.90 
Values are mean ± SEM (n = 6). *P ≤ 0.05 when compared with baseline values. 
a Glucose concentration in 
blood. Int. J. Mol. Sci. 2009, 10                 
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Plasma aminotransferase AST and ALT activities were determined in order to evaluate the safety of 
S. officinalis tea drinking in humans. Although a significant increase in plasma AST enzyme activity 
was observed at the fourth week of sage tea treatment (Table 1), toxicity did not occur, since the 
results are well below reference values (40 IU/L) [23,24]. Thus, drinking sage tea does not cause 
hepatotoxicity nor does it induce other adverse effects, such as changes in blood pressure, heart rate at 
rest and body weight (Table 1). 
In order to assess the effects of sage tea on glucose clearance, two OGTTs were performed, at 
baseline and at the end of sage tea treatment (four weeks after the first one), and no changes were 
observed (Table 2). Although all the volunteers were non-diabetic, they belong to an age group at risk 
of developing impaired glucose tolerance (IGT) (a pre-diabetic stage). All subjects showed no glucose 
intolerance. Although no effects on glucose regulation were observed in healthy humans, it remains to 
be established whether sage tea drinking helps to regulate blood glucose in hyperglycaemic patients.  
Table 2. Blood glucose concentration in response to an oral glucose tolerance test (OGTT). 
  Blood glucose levels (mM) 
Time  0 min  45 min  165 min 
Baseline  4.3 ± 1.2  5.5 ± 1.2  4.3 ± 0.4 
Treatment (4 weeks)  4.2 ± 1.5  6.9 ± 1.4  4.5 ± 0.9 
Values are mean ± SEM (n = 6). The reference values for a non-diabetic individual to the standard 
OGTT (75 g glucose/300 mL water) are: 3.33–5.56 mM (before glucose loading); < 10 mM   
(0.5–1.5 h after glucose loading) and 3.33–5.56 mM (3 h after glucose loading) [25]. 
 
2.2. Effects of Salvia officinalis on Lipid Profile  
 
Sage tea treatment reduced slightly plasma total cholesterol levels during treatment phase (by 4.5% 
at T2 and by 5.3% at T4), achieving a significant reduction two weeks after the end of the treatment 
(values 16% lower than the baseline; Figure 1A). A beneficial effect on lipoprotein levels, with a 
gradual reduction of LDL-C (of 12.4% at the end of the treatment and 19.6% after 2 weeks wash-out; 
Figure 1C) and a gradual increase of HDL-C levels (50.6% at the end of the treatment and 37.6% after 
two weeks wash-out; Figure 1B) were observed. The LDL-C/HDL-C ratio contributes to assess the 
risk of cardiovascular complications due to dyslipidemia [26]. As shown in Figure 1D, sage tea 
gradually decreased LDL-C/HDL-C ratio from baseline until the end of four weeks of tea treatment. 
This ratio remained significantly reduced even after the two week wash-out period (Figure 1D). These 
results suggest that S. officinalis tea consumption is accountable for the improvement of the lipid 
profile inducing a decrease on the higly atherogenic LDL-C particles (which are easily oxidable and 
less readily cleared [27]) and an increase in the HDL-C particles, contributing, therefore, positively to 
the control of the dyslipidaemia frequently observed in T2DM but also related to other diseases.  
A variety of pharmaceutical approaches have been developed in order to achieve both decrease of 
LDL-C and rise of HDL-C levels, with the aim to reduce the risk of CVD [4]. Despite the available 
therapies based on statins, niacin and fibrates (pharmacological agents used to lower plasma LDL-C 
and increase HDL-C levels), the need for more effective drugs drives the search for alternative Int. J. Mol. Sci. 2009, 10                 
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compounds. Several natural compounds have been shown to act on cholesterol metabolism (by 
reducing its absorption or its synthesis), such as phytosterols and catechins [28,29]. Extracts from 
some sage species have been shown to be effective in the prevention of cardiovascular diseases due to, 
at least in part, prevention of LDL-C oxidation [30]. Sage tea drinking had no significant effects on  
post-prandial triglycerides (data not shown). 
 
Figure 1. Total cholesterol [A], LDL cholesterol [B] and HDL cholesterol [C] levels as 
well as LDL-C/HDL-C ratio [D] in plasma measured at different points during the study: 
baseline (B), second (T2) and fourth week of treatment (T4), and wash-out (W). Values are 
mean ± SEM (n = 6). Groups with the same letter notation are not significantly different 
from each other (P > 0.05).  
 
2.3. Effects of Salvia officinalis on Antioxidant Defences and Heat-shock Protein 70 (Hsp70) 
Expression  
 
Sage tea drinking improved human erythrocyte antioxidant status by significantly increasing SOD 
and CAT activities after two weeks of sage treatment, returning afterwards to normal values   
(Figure 2A and 2B). The antioxidant properties of sage tea, in addition to preventing lipoprotein Int. J. Mol. Sci. 2009, 10                 
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oxidation, may also protect cells from diabetes’ related gluco- and lipotoxicity and prevent progressive 
β-cell destruction, which could provide long term protection of these insulin-producing cells. 
The antioxidant activity of phenolic compounds has been widely studied and it is known that these 
compounds can either stimulate endogenous antioxidant defence systems or scavenge reactive species 
[31]. Rosmarinic acid and luteolin-7-glucoside are the two most representative phenolic compounds 
present in our S. officinalis extracts (tea) [32]. These phenolic compounds showed protective effects 
against oxidative damage in hepatocytes, and limited GSH depletion induced by tert-butyl 
hydroperoxyde in HepG2, preserving cell viability [33]. The same happened for sage extracts in 
HepG2 cells [34]. In animals, sage tea drinking also stimulated several antioxidant enzymes in the 
liver [32,35], corroborating the effects of this tea in human erythrocytes observed in the present study.  
 
Figure 2. Antioxidant activities of SOD [A] and CAT [B] measured in haemolysed 
erythrocytes. Samples were taken at different time points during the study: baseline (B), 
second (T2) and fourth week of treatment (T4) and wash-out (W). Values are mean ± SEM 
(n = 6). Groups with the same letter notation are not significantly different from each other 
(P > 0.05). 
 
Since lymphocytes may provide valuable and easily accessible biomarkers of the health status of 
individuals [9,10] and heat shock proteins have been involved in tissue insulin responsiveness [8], the 
expression of Hsp70 in human lymphocyte lysates was evaluated. The lymphocyte’s inducible Hsp72 Int. J. Mol. Sci. 2009, 10                 
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protein not only significantly increased at the second week of S. officinalis tea treatment (about   
2.8-fold) but also remained elevated in the wash-out period (Figure 3). These findings suggest a 
beneficial potential of sage tea drinking on Hsp72 protein induction, an endogenous stress modulator, 
which plays a crucial role in cellular homeostasis decreasing the risk of development of T2DM by 
blocking inflammatory signalling molecules including c-Jun amino terminal kinase (JNK), inhibitor of 
kB kinase (IKK) and tumor necrosis factor-α (TNF-α) in insulin responsive tissues [36-39]. These 
molecules phosphorylate insulin receptor substrate-1 (IRS-1) in specific serine sites and determine 
decreased insulin sensitivity. Indeed, Hsp72 gene and protein expression has been shown to be 
significantly reduced in T2DM patients and correlated with reduced insulin sensitivity [40-42]. The 
antioxidant alpha-lipoic acid showed recently to improve insulin action in high-fat-fed rats by 
increasing the expression of Hsp72 and consequently inhibiting JNK and IKK [43]. Therefore, an 
increase in inducible Hsp70 protein expression by sage tea would represent an amelioration of   
whole-body insulin sensitivity although the assumption that lymphocyte Hsp levels mimic other 
tissues Hsp levels requires further demonstration. 
 
Figure 3. Western blot analysis of the inducible form of Hsp70 (Hsp72) in human 
lymphocytes at the different points during the study: baseline (B), second week of 
treatment (T2) and wash-out (W). [A] Values are mean ± SEM (n = 6). Groups with the 
same letter notation are not significantly different from each other (P > 0.05). [B] 
Representative immunoblots of three subjects (β-actin was used as loading control). 
 
Heat shock proteins confer also cytoprotection and assure survival after environmental stresses, 
being therefore implicated in infection, immunity and aging, as well as in ischemic and 
neurodegenerative diseases [44]. Thus, induction of Hsp72 by sage tea could also be useful by 
conferring stress tolerance and cytoprotection against several environmental-induced injury conditions 
helping increase lifespan and prevente age-related diseases such as diabetes, cancer and 
neurodegeneration. Natural compounds such as resveratrol have been shown recently to induce the 
heat-shock response and to protect human cells from severe heat stress [44]. As well, paeoniflorin Int. J. Mol. Sci. 2009, 10                 
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isolated from Paeonia lactifora showed to induce heat shock proteins expression and to afford 
termotolerance in cultured cells [45]. 
 
3. Experimental Section  
 
3.1. Subjects and Study Design  
 
Six healthy female volunteers (aged 40-50) participated in this trial after signing an informed 
consent form. The whole study was carried out in accordance with the principles of the Declaration of 
Helsinki. Smokers and subjects on regular medication were excluded from the study. Effects of sage 
tea drinking on body weight, blood pressure and heart rate at rest were recorded at first week of 
baseline and the end of each of the eight weeks of the trial. Weekly records of perceived negative 
events and concomitant medication were also kept. All the volunteers completed the study and 
reported no side effects. A non-randomized crossover study, where individuals serve as their own 
controls, was carried out in three phases: two weeks of baseline, four weeks of sage tea treatment and 
two weeks of wash-out (Figure 4). The two-week baseline phase was included in order to obtain 
control values for all the volunteers. During this phase, all the parameters were measured and values 
are presented in figures and tables as basal levels. A treatment phase with sage tea followed, where 
300 mL of tea were taken twice daily for four weeks. Sampling was carried out at the end of second 
and fourth week of sage treatment. A two-week wash-out phase was included after treatment with the 
aim to assess the duration of sage tea effects beyond the treatment period.  
 
Figure 4. Experimental outline of the pilot study. Blood samples were taken at the times 
indicated by the arrows. Oral glucose tolerance test were performed at the times indicated 
by the circles. 
 
3.2. Plant Material and Preparation of S. officinalis Tea  
 
Salvia officinalis L. plants were grown in an experimental farm located in Arouca, Portugal, and 
were collected in April, 2001. The aerial parts of plants were lyophilized and kept at -20 °C. The sage 
tea was routinely prepared by pouring 300 mL of boiling water onto 4 g dried plant material and 
allowing to steep for 5 min [32]. This infusion yielded about 3.5 ± 0.1 mg lyophilized extract dry 
weight per mL, where rosmarinic acid (362 mg/mL infusion) and luteolin-7-glucoside (115.3 mg/mL 
infusion) were the major phenolic compounds, and 1,8-cineole, cis-thujone, trans-thujone, camphor 
and borneol the major volatile components (4.8 mg/mL infusion). For full extract characterization  
see [32]. Int. J. Mol. Sci. 2009, 10                 
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3.3. Blood Samples, Erythrocytes’ Hemolysates and Lymphocytes Lysates 
 
At the different sampling points (baseline–B, second week of treatment–T2, fourth week of 
treatment–T4 and at the end of wash-out–W), venous blood samples were collected postprandially in 
EDTA vacutainers (Vacuett®, Greiner Bio-one GmbH, Austria). An aliquot of blood was used for 
measuring glucose levels. Immediately after sampling, about 3 mL of blood were centrifuged at 200× g 
(KUBOTA 2100, Tokyo, Japan) for 10 min to separate the plasma. Plasma aliquots were stored at  
-80 °C for later measurements of transaminases, total cholesterol, HDL-C and LDL-C levels. The 
remaining erythrocyte enriched fraction was haemolysed to analyse SOD and CAT activity. About  
10 mL of blood were used to separate peripheral blood lymphocytes (PBLs) by a Ficoll density 
gradient centrifugation following the procedure provided by the Ficoll manufacturer (Ficoll Paque-
Plus, GE Healthcare, Piscataway, NJ, USA). The resultant PBL fraction was collected, washed with 
PBS and the cell pellet was homogenised with lysis buffer (25 mM KH2PO4, pH 7.5, 2 mM MgCl2,  
5 mM KCl, 1 mM EDTA, 1 mM EGTA, with 0.1 mM PMSF and 2 mM DTT added fresh). Protein 
concentration from lymphocyte lysates was measured with the Bradford reagent (Sigma-Aldrich, Inc., 
St. Louis, MO, USA) and aliquots kept at -80 °C for later quantification of Hsp70.  
 
3.4. Measurement of Blood and Plasma Parameters 
 
3.4.1. Quantification of Glucose Levels and Oral Glucose Tolerance Test (OGTT) 
 
Fasting and postprandial glycaemia were measured with the Accutrend® GCT device (Roche 
Diagnostics GmbH, Mannheim, Germany) using Accutrend® test strips for glucose (Roche 
Diagnostics GmbH). Two OGTTs were performed after an overnight fast one at baseline and the other 
at week four of sage tea treatment. For that, 1 g of glucose per Kg body weight of each volunteer was 
given in up to 300 mL of warm water, which was consumed within 5 min of start. The OGTT started 
when the subjects began drinking with blood sampling taken before as well as at 45 min and 165 min 
after the oral glucose load. Blood glucose concentration was measured as above. 
 
3.4.2. Characterization of Lipid Profile 
 
Total plasma cholesterol, LDL-C and HDL-C levels were measured in plasma using 
spectrophotometric commercial kits from Spinreact (Girona, Spain), according to the manufacturer’s 
specifications.  
 
3.4.3. Quantification of Plasma Aminotransferases 
 
The alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities were 
measured spectrophotometrically in plasma following the NADH oxidation method at 340 nm on a 
plate reader (Spectra Max 340 pc, Molecular Devices, Sunnyvale, CA, USA), as previously   
described [32]. 
 Int. J. Mol. Sci. 2009, 10                 
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3.4.4. Quantification of Erythrocytes’ Antioxidant Defences 
 
The haemolysate fraction was used to determine SOD activity using the Ransod kit (Randox, 
Crumlin, UK) following the manufacturer’s specifications. The SOD activity in haemolysates was 
expressed as U/mL, with 1U corresponding to 50% of inhibition of 2-(4-iodophenyl)-3-(4-nitro-
phenol)-5-phenyltetrazolium chloride (INT) reduction under assay conditions. The same haemolysates 
were used to measure CAT activity as described elsewhere [46]. In brief, the decomposition of H2O2 
was followed at 240 nm in a spectrophotometer (Cary IE, UV-Visible Spectrophotometer Varian, 
Australia) and the activity expressed as U/mL (U being μmol of H2O2 decomposed per minute) using 
the molar extinction coefficient of 0.0394 mL μmol
-1 cm
-1.  
 
3.4.5. Western Blot Analyses  
 
The quantification of Hsp70 protein in lymphocyte lysates was assessed by Western Blot in which 
proteins (20 µg per sample) were separated by SDS-PAGE using the mini-PROTEAN   
3 electrophoresis cell (BioRad Laboratories, Inc., Hercules, CA, USA). Proteins were then transferred 
onto Hybond-P polyvinylidene difluoride membrane (GE Healthcare, UK) and membranes blocked in 
5% (w/v) non-fat dry milk in TPBS (0.05% (v/v) Tween 20 in PBS, pH 7.4). Blotted membranes were 
probed with mouse monoclonal antibodies against Hsp72 (StressGen, Assay Designs, Inc., Ann Arbor, 
MI, USA) and β-actin (Sigma; used as loading control). Bound antibodies were then detected by 
chemiluminescence using appropriate secondary antibodies and the reactive bands acquired with a 
ChemiDoc XRS (BioRad) imaging densitometer. Band intensity was quantified using the Quantity 
One image analysis software (BioRad). 
 
3.5. Statistical Analysis 
 
Data are expressed as means ± SEM (n = 6). For statistical analysis the different parameters were 
analysed by repeated one-way ANOVA measurements followed by the Student-Newman-Keuls   
post-test (GraphPad Prism, version 4.03; GraphPad Software Inc., San Diego, CA, USA) to identify 
differences between studied time points. P values ≤ 0.05 were considered statistically significant (with 
a confidence interval of 95%). 
 
4. Conclusions  
 
In conclusion, a four week treatment with sage tea was effective in the improvement of lipid profile, 
antioxidant defences and lymphocyte Hsp70 protein expression of human volunteers, which in the 
long term may be responsible for the general health improving properties attributed to sage. Our 
results support the popular believe that S. officinalis tea is beneficial and although not demonstrating 
effects on glucose regulation in healthy individuals, they show that sage tea drinking is safe and pave 
the way for sage’s effects to be tested in diabetic patients. 
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